Northern Trust Corp Purchases 967 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Northern Trust Corp increased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 4.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 25,379 shares of the financial services provider’s stock after acquiring an additional 967 shares during the period. Northern Trust Corp owned about 0.05% of iShares Biotechnology ETF worth $3,355,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Proficio Capital Partners LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $480,000. IFP Advisors Inc grew its holdings in iShares Biotechnology ETF by 237.1% during the fourth quarter. IFP Advisors Inc now owns 16,018 shares of the financial services provider’s stock valued at $2,118,000 after purchasing an additional 11,266 shares during the period. FineMark National Bank & Trust bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $319,000. Cullen Frost Bankers Inc. grew its holdings in iShares Biotechnology ETF by 1.5% during the fourth quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock valued at $748,000 after purchasing an additional 82 shares during the period. Finally, Modern Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $237,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.1%

Shares of iShares Biotechnology ETF stock opened at $121.25 on Friday. The company has a market capitalization of $5.30 billion, a price-to-earnings ratio of 23.96 and a beta of 0.84. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $150.57. The stock’s 50-day simple moving average is $122.58 and its 200-day simple moving average is $132.06.

iShares Biotechnology ETF Increases Dividend

The company also recently announced a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were given a $0.1212 dividend. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.